Screener
Phibro Animal Health PAHC Animal Health — Gain Loss Related To Litigation Settlement
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:GainLossRelatedToLitigationSettlement.
The source filing: Phibro Animal Health’s 10-Q, filed November 5, 2025.
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q3 2025
- Accession
- 0001104659-25-107001
| For the Periods Ended September 30 | Three Months / 2025 | Three Months / 2024 |
|---|---|---|
| Selling, general and administrative expenses (1) | 47,251 | 41,562 |
| Add: Depreciation and amortization | 11,599 | 7,663 |
| Add: Acquisition-related cost of goods sold (2) | 1,117 | — |
| Subtract: Insurance proceeds (4) | (1,177) | — |
| Adjusted EBITDA | 74,872 | 40,385 |
| Mineral Nutrition | ||
| Net sales | 62,988 | 59,062 |
| Cost of sales | 57,284 | 53,887 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phibro Animal Health's animal health — gain loss related to litigation settlement?
- Phibro Animal Health (PAHC) reported animal health — gain loss related to litigation settlement of $1.18M in Q3 2025.
- What does animal health — gain loss related to litigation settlement mean?
- This represents the financial impact of legal settlements, including gains or losses arising from litigation involving the animal health segment. It reflects the volatility associated with legal risks and regulatory challenges inherent in the animal health industry. This metric is critical for assessing the impact of non-operational legal events on segment earnings.
Ask your AI about Phibro Animal Health's animal health — gain loss related to litigation settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude